AHSP
Alpha-hemoglobin-stabilizing protein
Also known as: AHSP_HUMAN, EDRF, ERAF
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NZD4
- Gene
- AHSP
- Ensembl
- ENSG00000169877
- Chromosome
- 16
- Canonical length
- 102 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a molecular chaperone which binds specifically to free alpha-globin and is involved in hemoglobin assembly. The encoded protein binds to monomeric alpha-globin until it has been transferred to beta-globin to form a heterodimer, which in turn binds to another heterodimer to form the stable tetrameric hemoglobin. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
Canonical amino-acid sequenceUniProt
102 residues, UniProt reviewed canonical sequence.
>Q9NZD4|AHSP
1 MALLKANKDL ISAGLKEFSV LLNQQVFNDP LVSEEDMVTV VEDWMNFYIN YYRQQVTGEP
61 QERDKALQEL RQELNTLANP FLAKYRDFLK SHELPSHPPP SSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AHSP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 1,571 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 1,571 nTPM
- placenta: 25 nTPM
- spleen: 25 nTPM
- tongue: 8.3 nTPM
- liver: 5 nTPM
- lung: 5 nTPM
Single-cell type
- erythrocyte progenitors: 2,431 nCPM
- erythrocytes: 2,027 nCPM
- megakaryocyte-erythroid progenitors: 44 nCPM
- late spermatids: 38 nCPM
- early spermatids: 38 nCPM
- late primary spermatocytes: 13 nCPM
Immune cell
- total PBMC: 4.7 nTPM
- neutrophil: 0.5 nTPM
- memory B-cell: 0.2 nTPM
- memory CD8 T-cell: 0.1 nTPM
- myeloid DC: 0.1 nTPM
- naive CD8 T-cell: 0.1 nTPM
Brain region
- medulla oblongata: 0.5 nTPM
- white matter: 0.5 nTPM
- cerebral cortex: 0.4 nTPM
- midbrain: 0.4 nTPM
- pons: 0.4 nTPM
- spinal cord: 0.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.96
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.25
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- erythrocyte differentiation
- hemoglobin metabolic process
- hemopoiesis
- protein folding
- protein stabilization
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Alpha-haemoglobin stabilising protein
- AHSP superfamily
- Alpha-haemoglobin stabilising protein
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AHSP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AHSP as an antibody target. Whether an autoantibody or antibody against AHSP could matter depends on whether native AHSP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AHSP is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AHSP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...